Midazolam‑Ketamine versus Dexmedetomidine to prevent emergence delirium after deep sedation in children with burns
Official title: The Effect of Dormicum-Ketamine Versus Dexmedetomidine on Emergence Delirium During Deep Sedation in Paediatric Burn Patients
Run by Ain Shams University · NCT07519863 · Data updated 2026-11-12
We will try whether a midazolam‑ketamine combination or dexmedetomidine better prevents emergence delirium in children aged 3–16 undergoing deep sedation for burn dressing changes or minor procedures.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 3 Years to 16 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | November 20, 2025 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT07519863 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 3–16 years with ASA physical status I–II who are scheduled for elective burn dressing changes or minor interventions and have no significant hepatic, renal, immunological, hematological, or neurological disorders are ideal candidates.
✕Probably not a fit
Patients with hepatic or renal dysfunction, immunological/hematological disorders, epilepsy, developmental delay or neurological deficits, preoperative hemodynamic instability, need for high‑dose inotropes/vasopressors, or known allergy to the study drugs are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized, controlled Phase 2 study that assigns eligible pediatric burn patients to either an intravenous midazolam‑ketamine combination or intravenous dexmedetomidine for standardized deep sedation. Sedation depth will be kept comparable between groups using a validated sedation scale and standard intraoperative monitoring. Emergence delirium will be measured after the procedure using the Pediatric Anesthesia Emergence Delirium (PAED) scale as the primary outcome. Secondary outcomes include hemodynamic stability, recovery profile, postoperative pain scores, need for rescue medications, and adverse events.
Why it matters
Potential benefit: If successful, the preferred sedation approach could reduce the incidence of emergence delirium and improve recovery comfort and safety for children having burn procedures.
How similar studies have gone: Prior pediatric anesthesia studies have shown dexmedetomidine can reduce emergence delirium compared with some traditional sedatives, but direct comparisons with a midazolam‑ketamine combination specifically in burn deep sedation are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 3 to 16 years * Both sexes * Patients classified as American Society of Anesthesiologists (ASA) Physical -Status I-II * Patients scheduled for elective burn-related procedures (e.g., burn dressing changes or minor interventions) Exclusion Criteria: * Refusal or inability to provide written informed consent from parent or legal guardian * Known allergy or hypersensitivity to any of the study medications (midazolam, ketamine, or dexmedetomidine) * Presence of hepatic dysfunction * Presence of renal dysfunction * Presence of immunological or hematological disorders * History of epilepsy, developmental delay (mental retardation), or neurological deficits * Patients receiving or requiring high doses of inotropes and/or vasopressors intraoperatively or postoperatively * Preoperative hemodynamic instability, defined as uncontrolled hypertension, hypotension, or bradycardia
Where it's running
-
Ain Shams University
Cairo, Egypt Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing Paedfusor and Eleveld propofol TCI versus sevoflurane for reducing wake-up agitation in children
This project will test whether two propofol target-controlled infusion methods (Paedfusor and Eleveld) or sevoflurane inhalation better prevent awakening agitation in children aged 3–10 having planned urogenital surgery.
-
Greater auricular nerve block to reduce agitation after children's middle ear surgery
This trial will test whether an ultrasound-guided greater auricular nerve block can reduce agitation and pain when children wake up after microscopic middle ear surgery.
-
Personal versus hospital-provided dolls to comfort preschoolers during adenoidectomy or tonsillectomy
This tests whether a child's own doll or a hospital-provided doll reduces preoperative anxiety and emergence delirium in 3–7-year-old girls having elective adenoidectomy or tonsillectomy.
-
Ride-on toy car transfer for preschool boys going to the operating room
This trial will see if moving boys aged 3–7 to the operating room in a ride-on toy car reduces preoperative anxiety and emergence delirium compared with a standard stretcher.
-
Propofol vs. Dexmedetomidine for Preventing Emergence Agitation in Children After Sevoflurane Anesthesia
This trial tests whether a single dose of propofol or a single dose of dexmedetomidine, given after surgery, better prevents emergence agitation in children recovering from sevoflurane anesthesia.
-
EEG versus BIS monitoring to reduce emergence delirium in young children under general anaesthesia
This study will test whether using EEG or BIS monitoring during general anaesthesia helps reduce emergence delirium in children aged 1–6 having surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.